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Abstract
Introduction
• The Centers for Disease Control and Prevention (CDC) 
reported 1,708,569 lab confirmed Chlamydia cases 
and 555,608 cases of Gonorrhea in 2017. (CDC, 2017)
• GC infections remain a significant public health concern
• Current first-line treatment for GC includes injected 
ceftriaxone and oral azithromycin.
• Because of the stigmas surrounding STIs, many partners 
or contacts of patients may not present for treatment, or 
be willing to be seen.
Research Question
Literature Review
Applicability to Clinical Practice
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Discussion
• EPT remains a harm-reduction measure.
• Current research indicates that when compared with 
other forms of partner referral, EPT demonstrates 
superiority in reducing gonorrheal and chlamydial 
reinfection.
• Studies show good uptake of EPT by patients, and it had 
promise in potentially reaching more patients.
• A major drawback of EPT in 2019 is the lack of recent 
large, randomized controlled trials showing continued
efficacy of second-line oral cefixime.
• Emerging research does show promise with new 
experimental drugs (zoliflodacin) (Taylor, et al., 2018) 
and oral gemifloxacin, although the latter is associated 
with increased adverse effects.
• Although there is a need for further research into this 
topic given the urgency of a shifting microbiological 
climate, it appears that EPT remains the best alternative 
when sexual contacts are unable or unwilling to present 
to clinics for treatment.
Sexually transmitted infections (STI) such as Neisseria 
Gonorrhoeae and Chlamydia Trachomatis pose a 
challenge to the healthcare system worldwide. Treating 
sexual partners is as crucial to controlling the spread of 
these infections as treating index patients. However, 
because of problems associated with stigma, reaching 
affected populations, and ensuring follow-up, unique 
solutions are require to ensure partners receive treatment. 
One solution is Expedited Partner Therapy (EPT). EPT 
refers to treating patients, and providing necessary 
medication for both patient and partner. Current 
recommendations are for oral doses one gram of 
azithromycin and 400 milligrams of cefixime. This literature 
review looked at thirteen studies, and aimed to determine 
whether EPT is still superior to standard partner notification 
at reducing further infection, and reinfection in adult 
Gonorrhea and Chlamydia (GC) patients in the US. 
Research indicates that EPT remains a viable, cost-
effective measure at controlling the spread of GC 
infections. EPT appears to be the best available option 
despite use of second-line treatments in resistance-prone 
infections. Additionally, there is a need for future, large-
scale, US-based randomized controlled trials to 
unequivocally show the continued effectiveness of EPT.
Is Expedited Partner Therapy using oral cefixime and 
azithromycin for treatment of GC Infections still 
superior to standard partner notification among adult 
outpatients in the US in reducing further infection and 
reinfection rates?
EPT vs. Standard Partner Notification
• Golden, et. al. (2015) performed a large RCT showing 
significant increase in EPT use during a large, state-
wide campaign among Washington state public health 
clinics (p<0.001).
• Golden and Kerani, et. al. (2005) showed decrease in 
gonorrheal reinfections (p=0.01) but not chlamydial 
reinfections (p=0.17)
• Kissinger, et. al. (2005) also performed an RCT 
showing decreases in GC reinfection in a New Orleans 
STD clinic (p<0.001).
EPT Meta-Analyses
• Ferreira, et. al.’s 2013 Cochrane review of STD partner 
notification methods showed EPT to be superior to 
standard partner notification with EPT having a risk 
ratio of 0.71 (95% CI 0.56-0.89).
Efficacy of Cefixime as Second-Line Treatment
• Town, et. al. (2018) performed a recent analysis of 
previously used antibiotics. Results showed cefixime 
remained 96% effective among heterosexuals 
(p<0.001) and 82% effective among homosexuals 
(p=0.05).
Alternatives to Cefixime
• Kirkcaldy, et. al. (2014) showed effective treatment of 
Gonorrhea using oral gemifloxacin (99.5% cure rate), 
however was not a RCT, and gemifloxacin was noted 
to have nearly 7.5% rate of adverse effects.
Social and Economic Aspects of EPT
• Gift, et al. (2011) looked at cost-effectiveness of EPT 
and found it to be associated with significant cost 
savings (using Monte-Carlo statistical methods).
• Clark, et al. (2017) showed 83% of patients 
successfully informed their partners via EPT vs. 58.3% 
for standard patient referral. This study discussed the 
potential for EPT as a method of reaching patients at 
risk for HIV and syphilis infection as well.
• Evidence for EPT use is important to Family Medicine, 
Emergency Medicine, Urgent Care, Women’s and Sexual 
Health clinicians
• Should data emerge showing substantial reduction in GC 
susceptibility to cefixime, then EPT should be re-
evaluated to ensure it remains a viable option.
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Statement of the Problem
• Main drawback of EPT is its use of second-line oral 
antibiotic therapy (oral cefixime) in lieu of injectable 
ceftriaxone.
• EPT is harm reduction and is not considered the ideal 
form of treatment for GC infection.
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Expedited Partner Therapy
• EPT is a method for treating sexual partners of confirmed 
GC-infected patients.
• Legal in 43 States and DC
• Consists of medication packets, written prescriptions or 
offers of telephone prescriptions for sexual contacts.
Twoexamples of EPT packets, for Chlamydia (left) and one for 
Gonorrhea (right).
Source: Tacoma-Pierce County Health Department (fair use).
